SEC 13F Intelligence

Iszo Capital Management LP / LFCR

Iszo Capital Management LP’s Lifecore Biomedical Inc Position

Does Iszo Capital Management LP own Lifecore Biomedical Inc (LFCR)? Not currently — the last reported position was 373.8K shares worth $2M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$2M
Q4 2022
Shares
373.8K
% of Portfolio
+32.38%
Quarters Held
6
position exited

Position History LFCR

Reported value by quarter
Q3 ’21: $15MQ3 ’21Q4 ’21: $21MQ4 ’21Q1 ’22: $7MQ1 ’22Q2 ’22: $22MQ2 ’22Q3 ’22: $14MQ3 ’22Q4 ’22: $2MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022373.8K$2M+32.38%
Q3 20221.53M$14M+23.34%
Q2 20222.24M$22M+35.12%
Q1 20222.18M$7M+8.22%
Q4 20211.93M$21M+11.24%
Q3 20211.65M$15M+6.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Iszo Capital Management LP’s full portfolio or all institutional holders of LFCR.